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Herpes simplex virus type 1 (HSV-1) and some of its immediate-early genes stimulate expression of the 
human immunodeficiency virus (HIV) long terminal repeat (LTR) sequences and the replication of HIV itself. 
To demonstrate this, the HIV LTR was linked to the indicator gene chloramphenicol acetyltransferase (CAT) 
and transfected into Vero cells with or without the trans-activating gene (tat) of HIV. Infection of these cells with 
HSV-1 strain KOS or temperature-sensitive mutant tsB2l or tsE6 resulted in a large increase in CAT activity 
in the absence of tat and further augmentation in the presence of tat. This stimulation was seen at both their 
permissive (34°C) and nonpermissive (39OC) temperatures, implying either that HSV-1 infection or immediate- 
early gene expression is all that is required. In cotransfection assays in Vero cells, cloned HSV-1 immediate- 
early genes ICPO and ICP4 stimulated CAT activity in the presence of tat, while ICP27 had no effect. On the 
other hand, in SW480 cells, ICP4 and, to a lesser extent, ICPO genes caused stimulation of CAT activity in the 
absence of tat. Deletion mutants within the HIV LTR showed that the target for HSV stimulation is distinct 
from the tat-responsive area and maps near the SPl binding sites. In HeLa cells, ICPO or ICP4 stimulated the 
replication of a cotransfected clone of HIV, as shown by an increase in reverse transcriptase activity in the 
culture supernatant. 
The human immunodeficiency virus (HIV), also known as 
human T-lymphotropic virus type 111 or lymphadenopathy- 
associated virus, is a retrovirus that causes the acquired 
immune deficiency syndrome (2, 9, 22). Infected individuals 
often do not develop overt signs or symptoms of disease for 
many months to years (24). During this latent or disease-free 
phase, low numbers of HIV-infected cells (1 in lo4 to lo6 
infected lymphocytes) can be detected by in situ hybridiza- 
tion (15; Koenig and Gendelman, unpublished data). The 
mechanisms involved in maintenance of this low level of 
virus expression are not understood but may, in part, 
involve interactions between cellular and viral regulatory 
elements. Elucidation of these mechanisms could help de- 
termine why HIV remains quiescent in some persons but 
leads to fatal disease in others. 
The regulation of gene expression in HIV is complex. 
Transcription of viral mRNAs and progeny virion RNA 
originates from the viral long terminal repeat (LTR) se- 
quences. The HIV LTR contains transcriptional regulatory 
sequences present in many eucaryotic and viral promoters 
and includes a TATA box, three SP1 binding sites (7), a core 
enhancer region, and a negative regulatory region (17, 19, 
23). HIV also encodes a trans-activating protein (tat) whose 
target is in an area of the HIV LTR known as TAR, which 
maps between -17 and +80 bases relative to the cap site 
(34). tat exhibits multiple activities, including transcriptional 
activation and posttranscriptional enhancement of the 
expression of HIV mRNA (6, 34, 35, 38, 40, 41). An 
additional regulatory gene, the antirepression trans- 
activator, is involved in posttranscriptional events (34). 
Various stimuli, both infectious (viral infections and bac- 
terial products) and immunologic (mitogens and growth 
factors), stimulate expression of HIV in cultured lympho- 
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cytes and monocytes (10, 14, 42). We and others previously 
reported that herpes simplex virus (HSV) and other DNA 
virus sequences can stimulate expression of the HIV LTR 
(10, 25). HSV, a ubiquitous human pathogen that causes 
recurrent fever blisters, genital lesions, and other severe 
infections, replicates in a large number of human cell types, 
including human peripheral blood lymphocytes (28, 32). 
HSV replication is highly regulated, with three classes of 
genes expressed at different stages (16). The immediate-early 
(alpha) genes (ICPO, ICP4, ICP22, ICP27, and ICP47) appear 
to be regulatory in nature. Their transcription is dependent 
on host cell factors but can be stimulated by a component of 
the infecting virion. The proteins ICPO (VmwllO) and ICP4 
(Vmw175) trans-activate genes of the early (beta) and late 
(gamma) classes (8,17,29,30). ICP27 (Vmw63), on the other 
hand, appears to be involved in regulation of late protein 
synthesis (36). 
In this paper, we demonstrate that HSV infection of cells 
previously transfected with HIV LTR-cat can cause over- 
100-fold stimulation in chloramphenicol acetyltransferase 
(CAT) activity. In the presence of tat, further activation of 
the HIV LTR is seen. Experiments using a series of deletion 
mutants in the HIV LTR showed that the target for HSV 
activation maps near the SP1 binding sites and not the TAR 
region. In addition, we have shown that HSV immediate- 
early genes ICPO and ICP4 can stimulate activation of HIV 
LTR-cat, as well as production of HIV reverse transcriptase 
activity. These effects vary in different cell lines, implying 
that certain cellular factors, in addition to the immediate- 
early genes of HSV, are involved. 
MATERIALS AND METHODS 
Cells and viruses. Vero cells and low-passage HeLa-JW 
cells (a gift of Barrie Carter) were grown in a 1:l mixture of 
minimal essential medium and 199 medium containing peni- 
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FIG. 1. CAT activity in HSV-infected Vero cells transfected
with HIV LTR-cat. Cells were either mock transfected (lane 1) or
transfected with LTR-cat (lanes 2 to 5) or LTR-cat plus pAR(tat)
(lanes 6 to 9). At 24 h posttransfection, cells were mock infected
(lanes 2 and 6) or infected with 5 PFU of wild-type HSV-1 per cell
(lanes 3 and 7) or 5 PFU of the temperature-sensitive mutant tsE6
per cell (lanes 4 and 8) or tsB21 (lanes 5 and 9). Cell extracts were
harvested at 20 h postinfection, and CAT activity was assayed.
These experiments were carried out at the permissive (34°C; panel
A) and nonpermissive (39°C panel B) temperatures. CM,
Chloramphenicol.
cillin G (100 U/ml), streptomycin (100 ,ug/ml), and 10% fetal
bovine serum. SW480 cells, a human colon carcinoma cell
line (ATCC CCL228), were grown in Dulbecco minimal
essential medium as previously described (1). HSV type 1
strain KOS and temperature-sensitive mutants tsB21 and
tsE6 were kindly provided by Priscilla Schaffer.
Plasmids and DNA preparation. The HIV LTR was in-
serted upstream from the bacterial cat gene as previously
described (1, 10). An HIV tat-expressing plasmid, pAR(tat),
was generated from an infectious molecular clone of the
virus deleted in the structural and regulatory genes (10). The
HIV LTR-cat plasmids used in the deletion mutant studies
were derived from a parent LTR containing sequences from
-525 to +232 relative to the cap site and were generously
provided by Dan Capon. These mutants have deletions
within the LTR; for example, mutation dl -525/-98 lacks
sequences from -525 to -98 but contains the LTR se-
quences from -97 to +232 inserted upstream from the cat
gene (26). The HSV-containing clones ICP27 and ICPO are
pMC150 and pMC151, respectively, and were gifts of Mark
Challberg. The ICP4 clone, pEK1-2, was a gift of Neil
DeLuca. All plasmid DNAs were prepared as described by
Birnboim and Doly (3) and purified by isopycnic centrifuga-
tion in cesium chloride.
Transfections and infections. For CAT assays, cells were
grown to 70% confluence in 60-mm-diameter dishes. For
transfection, DNA samples were calcium phosphate copre-
cipitated by the method of Graham and Van der Eb (13). At
4 h after transfection, cells were washed in medium and
shocked for 2- to 4-min with 20% dimethyl sulfoxide. The
cells were then washed and placed in growth medium. At 24
h posttransfection, the medium was removed and selected
cultures were infected with 5 PFU of the appropriate HSV
strain per cell. After 1 h, the cells were fed with complete
medium and infection was allowed to proceed for an addi-
tional 20 h. Transfections involving the infectious clone of
HIV were carried out as before but in 25-cm2 screw-cap
tissue culture flasks. For these experiments, the medium was
removed at 12-h intervals and stored at -70°C to be assayed
later for reverse transcriptase activity.
CAT assays. Cell extracts were prepared as described by
Gorman et al. (12). All reaction mixtures were corrected for
protein content as determined by the method of Bradford (4).
Cell extracts were preheated at 65°C for 5 min before CAT
reactions. All reactions were carried out for 30 to 60 min and
maintained within the linear range of the assay. Following
incubation, reaction mixtures containing S ,uCi of [14C]
chloramphenicol (New England Nuclear Corp., Boston,
Mass.) were extracted with ethyl acetate, dried, and ana-
lyzed by ascending chromatography on silica gel thin-layer
chromatography plates in chloroform-methanol (95:5) as
previously described. The quantitation of percent conver-
sion was determined by recovering the acetylated and
nonacetylated forms of [14C]chloramphenicol from the silica
gel plates and counting them in a liquid scintillation counter.
Reverse transcriptase assay. Reverse transcriptase assays
with [32P]dTTP were performed by using a modification (R.
Willey et al., submitted for publication) of the protocol
described by Goff et al. (11). Reaction mixtures (50 p1l)
containing poly(A) (5 ,ug/ml) as the template and oligo(dT) (6
,ug/ml) as the primer, 50 mM Tris hydrochloride (pH 7.8), 75
mM KCl, 2 mM dithiothreitol, Nonidet P-40 (0.5%), 0.5 mM
MgC92, and [32P]dTTP (Amersham) were placed in individual
wells of a 96-well microtiter plate, and 10 ,ul of culture
supernatant was added. The plate was incubated for 3 h at
37°C. Ten microliters of the reaction mixture was spotted
onto Whatman DE81 paper, allowed to dry, and washed
extensively with 2x SSC (0.3 M sodium chloride, 0.03 M
sodium citrate). Autoradiography was performed overnight.
RESULTS
The ability of HSV type 1 to stimulate HIV-LTR-directed
gene expression was initially tested in Vero cells, a contin-
uous line of African Green Monkey kidney cells in which
HSV replicates efficiently. Cells were transfected with an
LTR-cat plasmid or cotransfected with both the LTR-cat
and pAR(tat) plasmids. At 24 h posttransfection, cells were
infected with HSV. When cells that had been cotransfected
with LTR-cat and saturating amounts of tat (10) were
superinfected with HSV, a further threefold stimulation
above that induced by tat alone was seen. These results were
observed at both 34 and 39°C (Fig. 1A and B, lanes 2, 6, and
7) and at 37°C (data not shown). Infection of cells containing
LTR-cat by temperature-sensitive mutants of HSV pro-
duced comparable levels of cat stimulation at both the
permissive (34°C) and nonpermissive (39°C) temperatures.
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Infection with tsE6, which is defective in the immediate-
early regulatory protein ICP27, and infection with tsB21,
which is defective in the immediate-early regulatory protein
ICP4, stimulated the HIV promoter to similar degrees (Fig.
1A and B, lanes 4 and 5), and further augmentation was seen
in the presence of tat (lanes 8 and 9).
To determine which HSV gene products play a role in this
stimulatory effect, clones containing individual HSV imme-
diate-early genes were transfected into Vero cells, and Fig. 2
shows their effect on HIV LTR-cat expression. Cells were
cotransfected with HIV LTR-cat and either pAR(tat), ICP0,
ICP4, or ICP27 or with a combination of pAR(tat) and the
individual HSV immediate-early genes. ICP0, 1CP4, or
ICP27 had no effect on cat expression in the absence of tat.
In the presence of pAR(tat), ICP4 and ICP0 produced a
three- to fourfold stimulatory effect on LTR-cat expression
above that seen with pAR(tat) alone, while ICP27 had no
effect. These results differ from those seen in SW480 cells, in
which ICP4 showed a marked stimulatory effect on CAT
activity, while ICPO and ICP27 produced little and r effect,
respectively (Fig. 3).
To identify the HIV LTR sequences which respond to
HSV activation, a series of LTR-cat deletion mutations from
the 5' and 3' ends ofpLTR (-525/+232 LTR sequences) (26)
were tested for their ability to be stimulated by HSV
infection. Figure 4 shows the entire sequence of the HIV
LTR and indicates many of its known regulatory elements
(26, 34, 35, 37-39). The LTR sequences deleted in each
construct are noted by black bars. Table 1 displays the basal
levels of expression of the pLTR-cat deletion constructs in
Vero cells. Plasmids with sequences deleted between
-5251-77 and -525/-30, which remove the SP1 binding
sites, had reduced basal levels of expression. Figure 5A (and
Table 1) demonstrates the effect of tat cotransfection on
these mutations. Two areas of the LTR seem to be necessary
for optimal activation by tat. Deletions within the TAR
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FIG. 2. Effect of clones containing HSV immediate-early genes
on the expression of HIV LTR-cat. Vero cells were mock
transfected (lane 1) or cotransfected with HIV LTR-cat alone (lane
2), HIV LTR-cat plus pAR(tat) (lane 3), ICP27 (lane 4), ICPO (lane
5), ICP4 (lane 6), pAR(tat) plus ICP27 (lane 7), pAR(tat) plus ICPO
(lane 8), or pAR(tat) plus ICP4 (lane 9). CM, Chloramphenicol.
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FIG. 3. Effect of clones containing HSV immediate-early genes
on the expression of HIV LTR-cat in SW480 cells. SW480 cells were
transfected with HIV LTR-cat (lane 1) or cotransfected with HIV
LTR-cat plus pAR(tat) (lane 2), ICPO (lane 3), ICP4 (lane 4), or
ICP27 (lane 5). CAT activity was assayed at 48 h posttransfection.
to stimulate LTR-cat expression (Fig. SA, lanes 12 to 14;
Table 1). Deletions removing the SP1 binding sites (Fig. SA,
lanes 5 to 8; Table 1) reduced the level of tat activation from
over 100-fold to 2- to 5-fold, in agreement with Muesing et al.
(26). Mutation dl +55/+232 (Fig. SA, lane 11) showed
reduced activation by tat, while mutations dl +32/+232, dl
+23/+232, and dl +6/+232 (Fig. SA, lanes 12 to 14) were not
activated by tat. Figure SB (and Table 1) demonstrates the
effect of HSV infection on cells transfected with pLTR-cat
and the series of deletion mutations. Lanes 10 to 14 show
that, when infected with HSV, cells transfected by plasmids
with deletions in which the entire TAR region was removed
showed levels of CAT activity similar to those of undeleted
LTR-cat. There was an 80 to 100% decrease in CAT activity
in cells transfected with plasmids containing deletions that
extend into the SP1 binding sites and then infected with HSV
(Fig. 5B, lanes 6 to 8). All other mutations showed greater
than 100-fold activation by HSV infection. Table 1 shows the
percent acetylation of chloramphenicol from Fig. 5A and B.
The experiments with HIV LTR-cat constructions dem-
onstrated the stimulatory effects of HSV on HIV LTR
activity and allowed identification of the HSV genes and
HIV regulatory sequences involved. To determine whether
the effects of HSV activation on the LTR-cat constructs
promote the replication of HIV, an infectious clone of HIV
was cotransfected into HeLa cells with the individual imme-
diate-early genes of HSV. Figure 6 shows the effect on HIV
replication of clones containing the individual HSV immedi-
ate-early gene products ICPO, ICP4, and ICP27 and an
HSV-1 DNA clone (pEcoC) that contains all three immedi-
ate-early genes (EcoRI-C). Reverse transcriptase activity in
the supernatants of HeLa cell cultures was assayed. Begin-
ning at 24 h posttransfection, reverse transcriptase activity
could be detected easily, whereas mock-infected cultures
had no activity (Fig. 6, lanes 1 and 2). Cotransfection of cells
with HSV, pEcoC, or the clones containing ICP4 or ICPO
had a five- to eightfold stimulatory effect on reverse trans-
criptase expression (lanes 3, 5, and 6), while ICP27 had no
effect. These data are consistent with those of Fig. 2 and 3,
showing the stimulatory effects of both ICP4 and ICPO.
J. VIROL.
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FIG. 6. The effect of clones containing HSV immediate-early
genes on HIV replication. HeLa cells were mock transfected (lane
1), transfected with an infectious clone (IC) of HIV (lane 2), or
cotransfected with the IC plus HSV pEco-C (lane 3), the IC plus
ICP27 (lane 4), the IC plus ICP4 (lane 5), or the IC plus ICPO (lane
6). Supematant fluid was replaced at the indicated times, and the
reverse transcriptase activity of a sample was assayed as described
in Materials and Methods. RT, Reverse transcriptase.
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FIG. 5. The effect of pAR(tat) cotransfection or HSV infection
on the expression of cat by HIV LTR-cat deletion mutants. Vero
cells were transfected with LTR-cat (lanes 1 and 2) or the series of
5' and 3' LTR-cat deletion mutants (lanes 3 to 14). Panel A shows
the results of CAT assays when pAR(tat) was cotransfected with the
LTR-cat constructs, and panel B shows the results of HSV infection
(5 PFU per cell) on cells previously (24 h) transfected with the HIV
LTR-cat constructs.
LTR-cat RNA were detected. The ability of herpes simplex
virus to activate an HIV LTR integrated into Vero cells has
also been reported (25).
The data presented here indicate that individual HSV gene
products can participate in LTR activation and the mecha-
nism of activation may vary in different cell lines. The
observation that ICP4 is able to induce activation of HIV
LTR-cat in SW480 but not in Vero cells suggests that SW480
cells already contain a cellular protein(s) that is otherwise
not present in Vero cells. Such a cellular protein would be
required for activation of the LTR by the cloned immediate-
early genes of HSV. The fact that HIV-LTR activation by
HSV infection occurs in Vero cells in the absence of tat
implies that HSV codes for, or introduces into the cell, a
protein that induces this putative cellular factor. Productive
replication of HSV is not necessary to induce this factor,
since ts mutants still activate the HIV LTR at the nonpermis-
sive temperature. Under these conditions, even though the
virus does not replicate, all other immediate-early gene
products are expressed and the trans-activating virion com-
ponent a-trans-inducing factor is introduced into the cell.
This may be responsible for the induction of this putative
cellular protein.
The observation that transfection of a tat-negative proviral
DNA results in some progeny virus production in SW480
cells, but much less in Vero cells, is also consistent with the
hypothesis that SW480 cells contain a cellular factor(s) not
found in Vero cells which affects LTR-directed viral gene
synthesis (H.E.G., unpublished data). It has been postulated
that HSV ICP4 trans-activates HSV early genes by interact-
ing with a cellular protein which in turn binds to sequences
within HSV early gene promoters (21). Infection of cells with
HSV may induce a number of cellular transcription factors
that are also necessary for HIV LTR activation. SP1 and
NF-kB are two such transcription-activating proteins that
are known to bind to the HIV LTR (18, 27). Three SP1
binding sites have been mapped to the area between -46 and
-78, and deletions encompassing this region fail to demon-
strate activation by HSV. Therefore, SP1 may be in part
responsible for the HSV effect. Two NF-kB binding sites
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